An update of the National Institute for Health and Care Excellence (NICE) guidelines for diagnosis and management of […]

Surveys uncovers findings pre- and post-pandemic

Final appraisal determination recommends anti-VEGF treatment for NHS use

New company will focus on developing bispecific antibodies for rare bleeding disorders

British drugmaker will acquire Alexion for approximately $39bn

Updated Date: Tue, 08 Dec 2020 00:00:00 EST

Updated Date: Tue, 08 Dec 2020 00:00:00 EST

Updated Date: Tue, 08 Dec 2020 00:00:00 EST

Updated Date: Tue, 08 Dec 2020 00:00:00 EST

Updated Date: Tue, 08 Dec 2020 00:00:00 EST